 Daniel Vargas
Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diagnostic Imaging | 5 | 2020 | 332 | 1.200 |
Why?
| | Tomography, X-Ray Computed | 11 | 2024 | 2691 | 1.060 |
Why?
| | Magnetic Resonance Imaging | 12 | 2024 | 3566 | 0.850 |
Why?
| | Aortic Coarctation | 2 | 2020 | 83 | 0.760 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2024 | 130 | 0.740 |
Why?
| | Foreign Bodies | 2 | 2024 | 104 | 0.730 |
Why?
| | Aortic Diseases | 1 | 2022 | 119 | 0.700 |
Why?
| | Thoracic Diseases | 2 | 2018 | 14 | 0.670 |
Why?
| | Computed Tomography Angiography | 4 | 2022 | 129 | 0.670 |
Why?
| | Radiography, Thoracic | 2 | 2018 | 167 | 0.650 |
Why?
| | Aorta | 5 | 2022 | 417 | 0.650 |
Why?
| | Cardiovascular Diseases | 4 | 2018 | 2111 | 0.590 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2018 | 18 | 0.590 |
Why?
| | Thorax | 1 | 2018 | 50 | 0.580 |
Why?
| | Prostheses and Implants | 1 | 2018 | 143 | 0.530 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 37 | 0.510 |
Why?
| | Mediastinal Diseases | 1 | 2015 | 10 | 0.500 |
Why?
| | Coronary Vessel Anomalies | 1 | 2016 | 35 | 0.490 |
Why?
| | Coronary Angiography | 2 | 2021 | 317 | 0.460 |
Why?
| | Cysts | 1 | 2015 | 113 | 0.460 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 580 | 0.440 |
Why?
| | Coronary Vessels | 1 | 2016 | 248 | 0.430 |
Why?
| | Pulmonary Artery | 2 | 2023 | 1086 | 0.420 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2020 | 193 | 0.390 |
Why?
| | Aneurysm, False | 2 | 2024 | 48 | 0.370 |
Why?
| | Lung | 1 | 2024 | 4060 | 0.360 |
Why?
| | Aortitis | 1 | 2011 | 10 | 0.350 |
Why?
| | Aortography | 1 | 2011 | 52 | 0.350 |
Why?
| | Vascular Stiffness | 3 | 2023 | 494 | 0.340 |
Why?
| | Heart Defects, Congenital | 1 | 2018 | 842 | 0.340 |
Why?
| | Multidetector Computed Tomography | 2 | 2024 | 39 | 0.330 |
Why?
| | Angiography | 1 | 2011 | 207 | 0.330 |
Why?
| | Cocaine-Related Disorders | 2 | 2008 | 113 | 0.320 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1587 | 0.320 |
Why?
| | Image Enhancement | 1 | 2011 | 190 | 0.320 |
Why?
| | Postoperative Complications | 2 | 2020 | 2654 | 0.300 |
Why?
| | Echocardiography | 4 | 2024 | 642 | 0.260 |
Why?
| | Humans | 34 | 2024 | 137585 | 0.250 |
Why?
| | Quality Improvement | 1 | 2014 | 1178 | 0.240 |
Why?
| | Radiology | 3 | 2015 | 180 | 0.240 |
Why?
| | Respiratory System Abnormalities | 1 | 2024 | 16 | 0.220 |
Why?
| | Contrast Media | 4 | 2020 | 467 | 0.220 |
Why?
| | Endocarditis, Bacterial | 1 | 2024 | 41 | 0.210 |
Why?
| | Endocarditis | 1 | 2024 | 37 | 0.210 |
Why?
| | Risk Assessment | 3 | 2024 | 3457 | 0.200 |
Why?
| | Prosthesis Design | 1 | 2024 | 327 | 0.180 |
Why?
| | Hypertension, Pulmonary | 3 | 2023 | 1910 | 0.180 |
Why?
| | Syndrome | 1 | 2022 | 358 | 0.180 |
Why?
| | Heart Aneurysm | 1 | 2019 | 11 | 0.160 |
Why?
| | Adipose Tissue | 1 | 2024 | 635 | 0.160 |
Why?
| | Chagas Cardiomyopathy | 1 | 2019 | 24 | 0.160 |
Why?
| | Acute Disease | 1 | 2022 | 1007 | 0.160 |
Why?
| | Pericardium | 2 | 2024 | 55 | 0.160 |
Why?
| | Heart | 3 | 2021 | 655 | 0.150 |
Why?
| | Equipment Safety | 1 | 2018 | 37 | 0.150 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 2031 | 0.140 |
Why?
| | Lung Diseases | 1 | 2024 | 767 | 0.140 |
Why?
| | Vasculitis | 1 | 2018 | 66 | 0.140 |
Why?
| | Dyspnea | 1 | 2019 | 254 | 0.140 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2020 | 238 | 0.140 |
Why?
| | Treatment Outcome | 2 | 2024 | 10811 | 0.140 |
Why?
| | Clinical Competence | 2 | 2015 | 1118 | 0.130 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 91 | 0.130 |
Why?
| | Coronary Artery Disease | 2 | 2021 | 698 | 0.130 |
Why?
| | Heart Ventricles | 2 | 2019 | 788 | 0.130 |
Why?
| | Diagnosis, Differential | 3 | 2016 | 1483 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 530 | 0.130 |
Why?
| | Equipment Design | 1 | 2018 | 522 | 0.130 |
Why?
| | Magnetic Resonance Angiography | 1 | 2018 | 240 | 0.130 |
Why?
| | Cardiomyopathy, Hypertrophic, Familial | 1 | 2016 | 16 | 0.130 |
Why?
| | Arteries | 1 | 2018 | 269 | 0.130 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2016 | 21 | 0.120 |
Why?
| | Radiology Department, Hospital | 1 | 2015 | 16 | 0.120 |
Why?
| | Incidental Findings | 1 | 2016 | 87 | 0.120 |
Why?
| | Pulmonary Valve | 1 | 2017 | 97 | 0.120 |
Why?
| | Heart Atria | 1 | 2016 | 137 | 0.120 |
Why?
| | Epinephrine | 1 | 2015 | 139 | 0.120 |
Why?
| | Pneumonia, Bacterial | 1 | 2016 | 116 | 0.110 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2017 | 180 | 0.110 |
Why?
| | Tendons | 1 | 2015 | 111 | 0.110 |
Why?
| | Accreditation | 1 | 2014 | 83 | 0.110 |
Why?
| | Pneumonectomy | 1 | 2016 | 152 | 0.110 |
Why?
| | Anaphylaxis | 1 | 2015 | 105 | 0.110 |
Why?
| | Brain Diseases | 2 | 2005 | 141 | 0.110 |
Why?
| | Biological Science Disciplines | 1 | 2013 | 17 | 0.110 |
Why?
| | Education, Graduate | 1 | 2013 | 34 | 0.100 |
Why?
| | Prognosis | 2 | 2020 | 4030 | 0.100 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1046 | 0.100 |
Why?
| | Heart Neoplasms | 1 | 2013 | 50 | 0.100 |
Why?
| | Emergency Medicine | 1 | 2015 | 226 | 0.100 |
Why?
| | Interprofessional Relations | 1 | 2015 | 283 | 0.100 |
Why?
| | Rhenium | 1 | 2012 | 4 | 0.100 |
Why?
| | Radioisotopes | 1 | 2012 | 31 | 0.100 |
Why?
| | Adult | 5 | 2024 | 37929 | 0.100 |
Why?
| | Incidence | 1 | 2018 | 2804 | 0.090 |
Why?
| | Brachytherapy | 1 | 2012 | 121 | 0.090 |
Why?
| | Decision Support Systems, Clinical | 1 | 2014 | 226 | 0.090 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5131 | 0.090 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 363 | 0.090 |
Why?
| | Internship and Residency | 2 | 2013 | 1147 | 0.080 |
Why?
| | Cardiomyopathies | 2 | 2016 | 350 | 0.080 |
Why?
| | Risk Factors | 1 | 2024 | 10388 | 0.080 |
Why?
| | Sternoclavicular Joint | 1 | 2009 | 11 | 0.080 |
Why?
| | Sternum | 1 | 2009 | 24 | 0.080 |
Why?
| | Referral and Consultation | 1 | 2015 | 786 | 0.080 |
Why?
| | Program Evaluation | 1 | 2013 | 898 | 0.080 |
Why?
| | Female | 9 | 2018 | 73304 | 0.070 |
Why?
| | Glioblastoma | 1 | 2012 | 345 | 0.070 |
Why?
| | Aortic Aneurysm | 1 | 2008 | 64 | 0.070 |
Why?
| | Glioma | 1 | 2012 | 395 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2015 | 986 | 0.070 |
Why?
| | Myocarditis | 1 | 2008 | 100 | 0.070 |
Why?
| | Male | 9 | 2019 | 67762 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 1171 | 0.070 |
Why?
| | Pulse Wave Analysis | 2 | 2018 | 272 | 0.070 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 263 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2018 | 6079 | 0.070 |
Why?
| | Curriculum | 1 | 2013 | 992 | 0.060 |
Why?
| | Child, Preschool | 2 | 2018 | 11074 | 0.060 |
Why?
| | Substance-Related Disorders | 2 | 2005 | 1083 | 0.060 |
Why?
| | Radiography | 1 | 2008 | 822 | 0.060 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 12 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1809 | 0.060 |
Why?
| | Tomography, Emission-Computed | 1 | 2005 | 66 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1724 | 0.060 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 80 | 0.060 |
Why?
| | Solvents | 1 | 2005 | 109 | 0.060 |
Why?
| | Central Nervous System Diseases | 1 | 2005 | 69 | 0.060 |
Why?
| | Quality of Life | 1 | 2016 | 2892 | 0.050 |
Why?
| | Hallucinogens | 1 | 2005 | 105 | 0.050 |
Why?
| | Multimodal Imaging | 1 | 2024 | 113 | 0.050 |
Why?
| | Middle Aged | 4 | 2018 | 33479 | 0.050 |
Why?
| | Education, Medical, Graduate | 1 | 2007 | 486 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 2012 | 1238 | 0.050 |
Why?
| | Marijuana Abuse | 1 | 2005 | 233 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2526 | 0.050 |
Why?
| | Echocardiography, Transesophageal | 1 | 2022 | 96 | 0.050 |
Why?
| | Disease Management | 2 | 2016 | 628 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2023 | 285 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2022 | 15657 | 0.040 |
Why?
| | Gadolinium | 1 | 2020 | 82 | 0.040 |
Why?
| | Chest Pain | 1 | 2020 | 91 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2023 | 530 | 0.040 |
Why?
| | Bolivia | 1 | 2019 | 65 | 0.040 |
Why?
| | Myocardium | 1 | 2024 | 1002 | 0.040 |
Why?
| | California | 1 | 2019 | 431 | 0.040 |
Why?
| | Shear Strength | 1 | 2018 | 67 | 0.040 |
Why?
| | Opioid-Related Disorders | 1 | 2005 | 515 | 0.030 |
Why?
| | Stroke Volume | 1 | 2020 | 612 | 0.030 |
Why?
| | Stents | 1 | 2021 | 527 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2018 | 413 | 0.030 |
Why?
| | Heart Septum | 1 | 2016 | 28 | 0.030 |
Why?
| | Penetrance | 1 | 2016 | 28 | 0.030 |
Why?
| | Mycobacterium chelonae | 1 | 2016 | 9 | 0.030 |
Why?
| | Genes, Dominant | 1 | 2016 | 96 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2018 | 485 | 0.030 |
Why?
| | Sympathomimetics | 1 | 2015 | 21 | 0.030 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2016 | 23 | 0.030 |
Why?
| | Membranes | 1 | 2015 | 19 | 0.030 |
Why?
| | Aged | 4 | 2019 | 23961 | 0.030 |
Why?
| | Sarcomeres | 1 | 2016 | 96 | 0.030 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2016 | 43 | 0.030 |
Why?
| | Risk | 1 | 2018 | 912 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2015 | 129 | 0.030 |
Why?
| | Mycobacterium avium Complex | 1 | 2016 | 88 | 0.030 |
Why?
| | Colorado | 2 | 2015 | 4565 | 0.030 |
Why?
| | Radiology Information Systems | 1 | 2015 | 30 | 0.030 |
Why?
| | Calcinosis | 1 | 2017 | 235 | 0.030 |
Why?
| | Atrophy | 2 | 2005 | 184 | 0.030 |
Why?
| | Preoperative Care | 1 | 2017 | 362 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2016 | 231 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 140 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2016 | 377 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 600 | 0.030 |
Why?
| | Child | 3 | 2018 | 21935 | 0.030 |
Why?
| | Workload | 1 | 2015 | 167 | 0.030 |
Why?
| | Hemodynamics | 1 | 2018 | 1113 | 0.030 |
Why?
| | Genetic Testing | 1 | 2016 | 460 | 0.020 |
Why?
| | Texas | 1 | 2013 | 244 | 0.020 |
Why?
| | Convection | 1 | 2012 | 6 | 0.020 |
Why?
| | Electrocardiography | 1 | 2015 | 629 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2013 | 173 | 0.020 |
Why?
| | Adolescent | 3 | 2018 | 21513 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 309 | 0.020 |
Why?
| | Educational Measurement | 1 | 2013 | 289 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3556 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 223 | 0.020 |
Why?
| | Funnel Chest | 1 | 2009 | 27 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 872 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2009 | 50 | 0.020 |
Why?
| | Arthritis | 1 | 2009 | 95 | 0.020 |
Why?
| | Disease Progression | 1 | 2016 | 2757 | 0.020 |
Why?
| | Osteomyelitis | 1 | 2009 | 132 | 0.020 |
Why?
| | Pregnancy | 2 | 2013 | 6763 | 0.020 |
Why?
| | Efficiency | 1 | 2007 | 99 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 13209 | 0.020 |
Why?
| | Research Support as Topic | 1 | 2007 | 119 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5472 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2009 | 247 | 0.020 |
Why?
| | Personnel Selection | 1 | 2007 | 78 | 0.020 |
Why?
| | Nanoparticles | 1 | 2012 | 481 | 0.020 |
Why?
| | Toluene | 1 | 2005 | 13 | 0.010 |
Why?
| | Cohort Studies | 1 | 2016 | 5742 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2009 | 380 | 0.010 |
Why?
| | Research | 1 | 2007 | 451 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9465 | 0.010 |
Why?
| | Prospective Studies | 1 | 2016 | 7604 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2005 | 688 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5647 | 0.010 |
Why?
| | Heart Failure | 1 | 2016 | 2236 | 0.010 |
Why?
| | United States | 1 | 2007 | 14841 | 0.010 |
Why?
| | Animals | 1 | 2012 | 36940 | 0.000 |
Why?
|
|
Vargas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|